instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'METHOTREXATE'? | Methotrexate-induced toxidermia and pancytopenia in a patient with ectopic pregnancy: a case report.
BACKGROUND
Methotrexate is an anticancer drug from the antimetabolite class. It is also used in gynecology and obstetrics and is the molecule of choice for the medical treatment of ectopic pregnancies. We report a case ... | Intramuscular | DrugAdministrationRoute | CC BY | 34872594 | 20,232,797 | 2021-12-07 |
What was the administration route of drug 'OMEPRAZOLE'? | Methotrexate-induced toxidermia and pancytopenia in a patient with ectopic pregnancy: a case report.
BACKGROUND
Methotrexate is an anticancer drug from the antimetabolite class. It is also used in gynecology and obstetrics and is the molecule of choice for the medical treatment of ectopic pregnancies. We report a case ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34872594 | 20,319,590 | 2021-12-07 |
What was the outcome of reaction 'Hepatic cytolysis'? | Methotrexate-induced toxidermia and pancytopenia in a patient with ectopic pregnancy: a case report.
BACKGROUND
Methotrexate is an anticancer drug from the antimetabolite class. It is also used in gynecology and obstetrics and is the molecule of choice for the medical treatment of ectopic pregnancies. We report a case ... | Fatal | ReactionOutcome | CC BY | 34872594 | 20,197,992 | 2021-12-07 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Methotrexate-induced toxidermia and pancytopenia in a patient with ectopic pregnancy: a case report.
BACKGROUND
Methotrexate is an anticancer drug from the antimetabolite class. It is also used in gynecology and obstetrics and is the molecule of choice for the medical treatment of ectopic pregnancies. We report a case ... | Fatal | ReactionOutcome | CC BY | 34872594 | 20,232,797 | 2021-12-07 |
What was the outcome of reaction 'Renal failure'? | Methotrexate-induced toxidermia and pancytopenia in a patient with ectopic pregnancy: a case report.
BACKGROUND
Methotrexate is an anticancer drug from the antimetabolite class. It is also used in gynecology and obstetrics and is the molecule of choice for the medical treatment of ectopic pregnancies. We report a case ... | Fatal | ReactionOutcome | CC BY | 34872594 | 20,197,992 | 2021-12-07 |
What was the outcome of reaction 'Septic shock'? | Methotrexate-induced toxidermia and pancytopenia in a patient with ectopic pregnancy: a case report.
BACKGROUND
Methotrexate is an anticancer drug from the antimetabolite class. It is also used in gynecology and obstetrics and is the molecule of choice for the medical treatment of ectopic pregnancies. We report a case ... | Fatal | ReactionOutcome | CC BY | 34872594 | 20,211,160 | 2021-12-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Factors.
BACKGROUND Edwardsiella tarda is a facultative anaerobic bacterium that is rarely pathogenic to humans, but, in patients with certain risk factors, it can lead to severe, disseminated infections. Humans are ... | ALBUTEROL\IPRATROPIUM, ASCORBIC ACID, CEFEPIME HYDROCHLORIDE, DEXTROSE, DOXYCYCLINE, HYDROCORTISONE BUTYRATE, LEVOFLOXACIN, METRONIDAZOLE, NOREPINEPHRINE, SODIUM BICARBONATE, TBO-FILGRASTIM, THIAMINE | DrugsGivenReaction | CC BY-NC-ND | 34873141 | 20,313,090 | 2021-12-07 |
What was the administration route of drug 'ALBUTEROL\IPRATROPIUM'? | Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Factors.
BACKGROUND Edwardsiella tarda is a facultative anaerobic bacterium that is rarely pathogenic to humans, but, in patients with certain risk factors, it can lead to severe, disseminated infections. Humans are ... | Nasal | DrugAdministrationRoute | CC BY-NC-ND | 34873141 | 20,333,229 | 2021-12-07 |
What was the administration route of drug 'ASCORBIC ACID'? | Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Factors.
BACKGROUND Edwardsiella tarda is a facultative anaerobic bacterium that is rarely pathogenic to humans, but, in patients with certain risk factors, it can lead to severe, disseminated infections. Humans are ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34873141 | 20,318,338 | 2021-12-07 |
What was the administration route of drug 'HYDROCORTISONE ACETATE'? | Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Factors.
BACKGROUND Edwardsiella tarda is a facultative anaerobic bacterium that is rarely pathogenic to humans, but, in patients with certain risk factors, it can lead to severe, disseminated infections. Humans are ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34873141 | 20,333,229 | 2021-12-07 |
What was the administration route of drug 'HYDROCORTISONE BUTYRATE'? | Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Factors.
BACKGROUND Edwardsiella tarda is a facultative anaerobic bacterium that is rarely pathogenic to humans, but, in patients with certain risk factors, it can lead to severe, disseminated infections. Humans are ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34873141 | 20,313,090 | 2021-12-07 |
What was the administration route of drug 'HYDROCORTISONE'? | Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Factors.
BACKGROUND Edwardsiella tarda is a facultative anaerobic bacterium that is rarely pathogenic to humans, but, in patients with certain risk factors, it can lead to severe, disseminated infections. Humans are ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34873141 | 20,318,338 | 2021-12-07 |
What was the administration route of drug 'SODIUM BICARBONATE'? | Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Factors.
BACKGROUND Edwardsiella tarda is a facultative anaerobic bacterium that is rarely pathogenic to humans, but, in patients with certain risk factors, it can lead to severe, disseminated infections. Humans are ... | Other | DrugAdministrationRoute | CC BY-NC-ND | 34873141 | 20,318,338 | 2021-12-07 |
What was the administration route of drug 'THIAMINE HYDROCHLORIDE'? | Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Factors.
BACKGROUND Edwardsiella tarda is a facultative anaerobic bacterium that is rarely pathogenic to humans, but, in patients with certain risk factors, it can lead to severe, disseminated infections. Humans are ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34873141 | 20,304,213 | 2021-12-07 |
What was the administration route of drug 'THIAMINE'? | Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Factors.
BACKGROUND Edwardsiella tarda is a facultative anaerobic bacterium that is rarely pathogenic to humans, but, in patients with certain risk factors, it can lead to severe, disseminated infections. Humans are ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34873141 | 20,318,338 | 2021-12-07 |
What was the dosage of drug 'HYDROCORTISONE ACETATE'? | Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Factors.
BACKGROUND Edwardsiella tarda is a facultative anaerobic bacterium that is rarely pathogenic to humans, but, in patients with certain risk factors, it can lead to severe, disseminated infections. Humans are ... | 100 MG, 4X/DAY | DrugDosageText | CC BY-NC-ND | 34873141 | 20,333,229 | 2021-12-07 |
What was the outcome of reaction 'Drug ineffective for unapproved indication'? | Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Factors.
BACKGROUND Edwardsiella tarda is a facultative anaerobic bacterium that is rarely pathogenic to humans, but, in patients with certain risk factors, it can lead to severe, disseminated infections. Humans are ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34873141 | 20,313,090 | 2021-12-07 |
What was the outcome of reaction 'Drug ineffective'? | Edwardsiella tarda: A Classic Presentation of a Rare Fatal Infection, with Possible New Background Risk Factors.
BACKGROUND Edwardsiella tarda is a facultative anaerobic bacterium that is rarely pathogenic to humans, but, in patients with certain risk factors, it can lead to severe, disseminated infections. Humans are ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34873141 | 20,318,338 | 2021-12-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug reaction with eosinophilia and systemic symptoms'. | Drug Reaction With Eosinophilia and Systemic Symptom (DRESS) Following Rifampicin Treatment: A Case Report.
Drug reaction with eosinophilia and systemic symptoms (DRESS) is an idiosyncratic severe cutaneous adverse reaction (SCAR) characterized by a skin rash with systemic involvement (e.g., hematological, solid organ ... | ISONIAZID, RIFAMPIN | DrugsGivenReaction | CC BY | 34873548 | 20,091,499 | 2021-11 |
What was the dosage of drug 'RIFAMPIN'? | Drug Reaction With Eosinophilia and Systemic Symptom (DRESS) Following Rifampicin Treatment: A Case Report.
Drug reaction with eosinophilia and systemic symptoms (DRESS) is an idiosyncratic severe cutaneous adverse reaction (SCAR) characterized by a skin rash with systemic involvement (e.g., hematological, solid organ ... | 75 MG (RECHALLENGE TEST) | DrugDosageText | CC BY | 34873548 | 20,091,499 | 2021-11 |
What was the outcome of reaction 'Drug reaction with eosinophilia and systemic symptoms'? | Drug Reaction With Eosinophilia and Systemic Symptom (DRESS) Following Rifampicin Treatment: A Case Report.
Drug reaction with eosinophilia and systemic symptoms (DRESS) is an idiosyncratic severe cutaneous adverse reaction (SCAR) characterized by a skin rash with systemic involvement (e.g., hematological, solid organ ... | Recovered | ReactionOutcome | CC BY | 34873548 | 20,091,499 | 2021-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diffuse alveolar damage'. | Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia.
A 72-year-old Japanese man was admitted to our hospital for treatment of severe COVID-19 pneumonia and was started on favipiravir, heparin calcium, and methylprednisolone pulse therapy. He recovered from respiratory failure about one mo... | AZITHROMYCIN, HEPARIN CALCIUM, METHYLPREDNISOLONE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | DrugsGivenReaction | CC BY-NC-ND | 34873569 | 20,344,298 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage'. | Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia.
A 72-year-old Japanese man was admitted to our hospital for treatment of severe COVID-19 pneumonia and was started on favipiravir, heparin calcium, and methylprednisolone pulse therapy. He recovered from respiratory failure about one mo... | AZITHROMYCIN, HEPARIN CALCIUM, METHYLPREDNISOLONE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | DrugsGivenReaction | CC BY-NC-ND | 34873569 | 20,344,298 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune thrombocytopenia'. | Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia.
A 72-year-old Japanese man was admitted to our hospital for treatment of severe COVID-19 pneumonia and was started on favipiravir, heparin calcium, and methylprednisolone pulse therapy. He recovered from respiratory failure about one mo... | AZITHROMYCIN, HEPARIN CALCIUM, METHYLPREDNISOLONE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM | DrugsGivenReaction | CC BY-NC-ND | 34873569 | 20,344,298 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Impaired healing'. | Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia.
A 72-year-old Japanese man was admitted to our hospital for treatment of severe COVID-19 pneumonia and was started on favipiravir, heparin calcium, and methylprednisolone pulse therapy. He recovered from respiratory failure about one mo... | AZITHROMYCIN, FAVIPIRAVIR, HEPARIN CALCIUM, METHYLPREDNISOLONE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34873569 | 20,338,705 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia.
A 72-year-old Japanese man was admitted to our hospital for treatment of severe COVID-19 pneumonia and was started on favipiravir, heparin calcium, and methylprednisolone pulse therapy. He recovered from respiratory failure about one mo... | AZITHROMYCIN, FAVIPIRAVIR, HEPARIN CALCIUM, METHYLPREDNISOLONE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34873569 | 20,338,705 | 2021 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia.
A 72-year-old Japanese man was admitted to our hospital for treatment of severe COVID-19 pneumonia and was started on favipiravir, heparin calcium, and methylprednisolone pulse therapy. He recovered from respiratory failure about one mo... | 1 GRAM, QD (PULSE THERAPY) | DrugDosageText | CC BY-NC-ND | 34873569 | 20,338,705 | 2021 |
What was the outcome of reaction 'Diffuse alveolar damage'? | Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia.
A 72-year-old Japanese man was admitted to our hospital for treatment of severe COVID-19 pneumonia and was started on favipiravir, heparin calcium, and methylprednisolone pulse therapy. He recovered from respiratory failure about one mo... | Recovering | ReactionOutcome | CC BY-NC-ND | 34873569 | 20,344,298 | 2021 |
What was the outcome of reaction 'Haemorrhage'? | Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia.
A 72-year-old Japanese man was admitted to our hospital for treatment of severe COVID-19 pneumonia and was started on favipiravir, heparin calcium, and methylprednisolone pulse therapy. He recovered from respiratory failure about one mo... | Recovering | ReactionOutcome | CC BY-NC-ND | 34873569 | 20,344,298 | 2021 |
What was the outcome of reaction 'Immune thrombocytopenia'? | Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia.
A 72-year-old Japanese man was admitted to our hospital for treatment of severe COVID-19 pneumonia and was started on favipiravir, heparin calcium, and methylprednisolone pulse therapy. He recovered from respiratory failure about one mo... | Recovered | ReactionOutcome | CC BY-NC-ND | 34873569 | 20,344,298 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Rituximab in glomerular diseases: a case series and narrative review.
BACKGROUND
The use of Rituximab (RTX) in glomerular diseases (GD) has increased in the past years, although it is still only used in a small fraction of patients.
METHODS
A single center retrospective study of adult patients with membranous nephrop... | RITUXIMAB | DrugsGivenReaction | CC BY | 34874051 | 20,360,208 | 2021-12-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Rituximab in glomerular diseases: a case series and narrative review.
BACKGROUND
The use of Rituximab (RTX) in glomerular diseases (GD) has increased in the past years, although it is still only used in a small fraction of patients.
METHODS
A single center retrospective study of adult patients with membranous nephrop... | RITUXIMAB | DrugsGivenReaction | CC BY | 34874051 | 20,360,208 | 2021-12-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory tract infection'. | Rituximab in glomerular diseases: a case series and narrative review.
BACKGROUND
The use of Rituximab (RTX) in glomerular diseases (GD) has increased in the past years, although it is still only used in a small fraction of patients.
METHODS
A single center retrospective study of adult patients with membranous nephrop... | RITUXIMAB | DrugsGivenReaction | CC BY | 34874051 | 20,360,208 | 2021-12-03 |
What was the administration route of drug 'RITUXIMAB'? | Rituximab in glomerular diseases: a case series and narrative review.
BACKGROUND
The use of Rituximab (RTX) in glomerular diseases (GD) has increased in the past years, although it is still only used in a small fraction of patients.
METHODS
A single center retrospective study of adult patients with membranous nephrop... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34874051 | 20,360,208 | 2021-12-03 |
What was the dosage of drug 'RITUXIMAB'? | Rituximab in glomerular diseases: a case series and narrative review.
BACKGROUND
The use of Rituximab (RTX) in glomerular diseases (GD) has increased in the past years, although it is still only used in a small fraction of patients.
METHODS
A single center retrospective study of adult patients with membranous nephrop... | UNK (INFUSION OF 3-4 H) | DrugDosageText | CC BY | 34874051 | 20,360,208 | 2021-12-03 |
What was the outcome of reaction 'Respiratory tract infection'? | Rituximab in glomerular diseases: a case series and narrative review.
BACKGROUND
The use of Rituximab (RTX) in glomerular diseases (GD) has increased in the past years, although it is still only used in a small fraction of patients.
METHODS
A single center retrospective study of adult patients with membranous nephrop... | Recovered | ReactionOutcome | CC BY | 34874051 | 20,360,208 | 2021-12-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthritis reactive'. | Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report.
BACKGROUND
To manage severe or potentially severe cases of CoronaVirus Disease 2019 (COVID-19), therapeutic monoclonal antibodies targeting Spike protein of Severe Acute Respiratory ... | CYCLOPHOSPHAMIDE, DOXORUBICIN, OBINUTUZUMAB, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY | 34876033 | 20,515,714 | 2021-12-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report.
BACKGROUND
To manage severe or potentially severe cases of CoronaVirus Disease 2019 (COVID-19), therapeutic monoclonal antibodies targeting Spike protein of Severe Acute Respiratory ... | CYCLOPHOSPHAMIDE, DOXORUBICIN, OBINUTUZUMAB, PREDNISOLONE, VINCRISTINE | DrugsGivenReaction | CC BY | 34876033 | 20,488,938 | 2021-12-07 |
What was the administration route of drug 'HUMAN PLASMA'? | Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report.
BACKGROUND
To manage severe or potentially severe cases of CoronaVirus Disease 2019 (COVID-19), therapeutic monoclonal antibodies targeting Spike protein of Severe Acute Respiratory ... | Other | DrugAdministrationRoute | CC BY | 34876033 | 20,541,639 | 2021-12-07 |
What was the dosage of drug 'COVID-19 CONVALESCENT PLASMA'? | Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report.
BACKGROUND
To manage severe or potentially severe cases of CoronaVirus Disease 2019 (COVID-19), therapeutic monoclonal antibodies targeting Spike protein of Severe Acute Respiratory ... | UNK; ON APRIL 30TH AND MAY 1ST | DrugDosageText | CC BY | 34876033 | 20,484,323 | 2021-12-07 |
What was the dosage of drug 'PREDNISOLONE'? | Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report.
BACKGROUND
To manage severe or potentially severe cases of CoronaVirus Disease 2019 (COVID-19), therapeutic monoclonal antibodies targeting Spike protein of Severe Acute Respiratory ... | UNK, CHOP CHEMOTHERAPY REGIMEN | DrugDosageText | CC BY | 34876033 | 20,488,938 | 2021-12-07 |
What was the outcome of reaction 'COVID-19 pneumonia'? | Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report.
BACKGROUND
To manage severe or potentially severe cases of CoronaVirus Disease 2019 (COVID-19), therapeutic monoclonal antibodies targeting Spike protein of Severe Acute Respiratory ... | Recovered | ReactionOutcome | CC BY | 34876033 | 20,488,938 | 2021-12-07 |
What was the outcome of reaction 'COVID-19'? | Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report.
BACKGROUND
To manage severe or potentially severe cases of CoronaVirus Disease 2019 (COVID-19), therapeutic monoclonal antibodies targeting Spike protein of Severe Acute Respiratory ... | Recovered | ReactionOutcome | CC BY | 34876033 | 20,488,938 | 2021-12-07 |
What was the outcome of reaction 'Condition aggravated'? | Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report.
BACKGROUND
To manage severe or potentially severe cases of CoronaVirus Disease 2019 (COVID-19), therapeutic monoclonal antibodies targeting Spike protein of Severe Acute Respiratory ... | Recovered | ReactionOutcome | CC BY | 34876033 | 20,488,938 | 2021-12-07 |
What was the outcome of reaction 'Hypoxia'? | Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report.
BACKGROUND
To manage severe or potentially severe cases of CoronaVirus Disease 2019 (COVID-19), therapeutic monoclonal antibodies targeting Spike protein of Severe Acute Respiratory ... | Recovered | ReactionOutcome | CC BY | 34876033 | 20,488,938 | 2021-12-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebral venous sinus thrombosis'. | Complicated Trichosporon asahii mastoiditis in immunocompetent child.
BACKGROUND
Trichosporon asahii is an opportunistic fungus that causes infections in immunosuppressed patients. It is rarely seen in children and immunocompetent hosts. The mortality rates are still high despite early treatment with proper antifungal ... | AMOXICILLIN, AMOXICILLIN\CLAVULANIC ACID, AZITHROMYCIN, ENOXAPARIN, MEROPENEM | DrugsGivenReaction | CC BY | 34876058 | 20,323,817 | 2021-12-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Complicated Trichosporon asahii mastoiditis in immunocompetent child.
BACKGROUND
Trichosporon asahii is an opportunistic fungus that causes infections in immunosuppressed patients. It is rarely seen in children and immunocompetent hosts. The mortality rates are still high despite early treatment with proper antifungal ... | AMOXICILLIN, AMOXICILLIN\CLAVULANIC ACID, AZITHROMYCIN, MEROPENEM | DrugsGivenReaction | CC BY | 34876058 | 20,330,455 | 2021-12-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mastoiditis fungal'. | Complicated Trichosporon asahii mastoiditis in immunocompetent child.
BACKGROUND
Trichosporon asahii is an opportunistic fungus that causes infections in immunosuppressed patients. It is rarely seen in children and immunocompetent hosts. The mortality rates are still high despite early treatment with proper antifungal ... | AMOXICILLIN, AMOXICILLIN\CLAVULANIC ACID, AZITHROMYCIN, ENOXAPARIN, MEROPENEM | DrugsGivenReaction | CC BY | 34876058 | 20,323,817 | 2021-12-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mastoiditis'. | Complicated Trichosporon asahii mastoiditis in immunocompetent child.
BACKGROUND
Trichosporon asahii is an opportunistic fungus that causes infections in immunosuppressed patients. It is rarely seen in children and immunocompetent hosts. The mortality rates are still high despite early treatment with proper antifungal ... | AMOXICILLIN, AMOXICILLIN\CLAVULANIC ACID, AZITHROMYCIN | DrugsGivenReaction | CC BY | 34876058 | 20,367,320 | 2021-12-07 |
What was the administration route of drug 'AMOXICILLIN'? | Complicated Trichosporon asahii mastoiditis in immunocompetent child.
BACKGROUND
Trichosporon asahii is an opportunistic fungus that causes infections in immunosuppressed patients. It is rarely seen in children and immunocompetent hosts. The mortality rates are still high despite early treatment with proper antifungal ... | Oral | DrugAdministrationRoute | CC BY | 34876058 | 20,330,455 | 2021-12-07 |
What was the administration route of drug 'AMOXICILLIN\CLAVULANIC ACID'? | Complicated Trichosporon asahii mastoiditis in immunocompetent child.
BACKGROUND
Trichosporon asahii is an opportunistic fungus that causes infections in immunosuppressed patients. It is rarely seen in children and immunocompetent hosts. The mortality rates are still high despite early treatment with proper antifungal ... | Oral | DrugAdministrationRoute | CC BY | 34876058 | 20,323,817 | 2021-12-07 |
What was the administration route of drug 'MEROPENEM'? | Complicated Trichosporon asahii mastoiditis in immunocompetent child.
BACKGROUND
Trichosporon asahii is an opportunistic fungus that causes infections in immunosuppressed patients. It is rarely seen in children and immunocompetent hosts. The mortality rates are still high despite early treatment with proper antifungal ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34876058 | 20,323,817 | 2021-12-07 |
What was the dosage of drug 'AMOXICILLIN\CLAVULANIC ACID'? | Complicated Trichosporon asahii mastoiditis in immunocompetent child.
BACKGROUND
Trichosporon asahii is an opportunistic fungus that causes infections in immunosuppressed patients. It is rarely seen in children and immunocompetent hosts. The mortality rates are still high despite early treatment with proper antifungal ... | HIGH DOSE | DrugDosageText | CC BY | 34876058 | 20,323,817 | 2021-12-07 |
What was the outcome of reaction 'Cerebral venous sinus thrombosis'? | Complicated Trichosporon asahii mastoiditis in immunocompetent child.
BACKGROUND
Trichosporon asahii is an opportunistic fungus that causes infections in immunosuppressed patients. It is rarely seen in children and immunocompetent hosts. The mortality rates are still high despite early treatment with proper antifungal ... | Recovered | ReactionOutcome | CC BY | 34876058 | 20,323,817 | 2021-12-07 |
What was the outcome of reaction 'Condition aggravated'? | Complicated Trichosporon asahii mastoiditis in immunocompetent child.
BACKGROUND
Trichosporon asahii is an opportunistic fungus that causes infections in immunosuppressed patients. It is rarely seen in children and immunocompetent hosts. The mortality rates are still high despite early treatment with proper antifungal ... | Recovering | ReactionOutcome | CC BY | 34876058 | 20,330,455 | 2021-12-07 |
What was the outcome of reaction 'Mastoiditis fungal'? | Complicated Trichosporon asahii mastoiditis in immunocompetent child.
BACKGROUND
Trichosporon asahii is an opportunistic fungus that causes infections in immunosuppressed patients. It is rarely seen in children and immunocompetent hosts. The mortality rates are still high despite early treatment with proper antifungal ... | Recovered | ReactionOutcome | CC BY | 34876058 | 20,323,817 | 2021-12-07 |
What was the outcome of reaction 'Mastoiditis'? | Complicated Trichosporon asahii mastoiditis in immunocompetent child.
BACKGROUND
Trichosporon asahii is an opportunistic fungus that causes infections in immunosuppressed patients. It is rarely seen in children and immunocompetent hosts. The mortality rates are still high despite early treatment with proper antifungal ... | Recovered | ReactionOutcome | CC BY | 34876058 | 20,367,320 | 2021-12-07 |
What was the outcome of reaction 'Trichosporon infection'? | Complicated Trichosporon asahii mastoiditis in immunocompetent child.
BACKGROUND
Trichosporon asahii is an opportunistic fungus that causes infections in immunosuppressed patients. It is rarely seen in children and immunocompetent hosts. The mortality rates are still high despite early treatment with proper antifungal ... | Recovered | ReactionOutcome | CC BY | 34876058 | 20,323,817 | 2021-12-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Corneal erosion'. | "Real-life" data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma-the Mayo Clinic experience.
Belantamab mafodotin is a highly selective targeted therapy for multiple myeloma. It targets the B cell maturation antigen (BCMA) on plasma cells and showed promising results in several randomize... | BELANTAMAB MAFODOTIN | DrugsGivenReaction | CC BY | 34876555 | 20,198,553 | 2021-12-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | "Real-life" data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma-the Mayo Clinic experience.
Belantamab mafodotin is a highly selective targeted therapy for multiple myeloma. It targets the B cell maturation antigen (BCMA) on plasma cells and showed promising results in several randomize... | BELANTAMAB MAFODOTIN | DrugsGivenReaction | CC BY | 34876555 | 20,198,554 | 2021-12-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tumour lysis syndrome'. | "Real-life" data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma-the Mayo Clinic experience.
Belantamab mafodotin is a highly selective targeted therapy for multiple myeloma. It targets the B cell maturation antigen (BCMA) on plasma cells and showed promising results in several randomize... | BELANTAMAB MAFODOTIN | DrugsGivenReaction | CC BY | 34876555 | 20,198,554 | 2021-12-07 |
What was the administration route of drug 'BELANTAMAB MAFODOTIN'? | "Real-life" data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma-the Mayo Clinic experience.
Belantamab mafodotin is a highly selective targeted therapy for multiple myeloma. It targets the B cell maturation antigen (BCMA) on plasma cells and showed promising results in several randomize... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34876555 | 20,198,554 | 2021-12-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience.
Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) have poor outcomes. Treatment with CD19 chimeric antigen receptor (CAR-T... | CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 34876852 | 20,209,876 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diffuse large B-cell lymphoma'. | Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience.
Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) have poor outcomes. Treatment with CD19 chimeric antigen receptor (CAR-T... | CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 34876852 | 20,209,876 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience.
Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) have poor outcomes. Treatment with CD19 chimeric antigen receptor (CAR-T... | CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 34876852 | 20,209,876 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Follicular lymphoma'. | Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience.
Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) have poor outcomes. Treatment with CD19 chimeric antigen receptor (CAR-T... | CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 34876852 | 20,209,876 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience.
Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) have poor outcomes. Treatment with CD19 chimeric antigen receptor (CAR-T... | CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 34876852 | 20,209,876 | 2021 |
What was the outcome of reaction 'Death'? | Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience.
Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) have poor outcomes. Treatment with CD19 chimeric antigen receptor (CAR-T... | Fatal | ReactionOutcome | CC BY-NC | 34876852 | 20,209,876 | 2021 |
What was the outcome of reaction 'Diffuse large B-cell lymphoma'? | Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience.
Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) have poor outcomes. Treatment with CD19 chimeric antigen receptor (CAR-T... | Fatal | ReactionOutcome | CC BY-NC | 34876852 | 20,209,876 | 2021 |
What was the outcome of reaction 'Follicular lymphoma'? | Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience.
Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) have poor outcomes. Treatment with CD19 chimeric antigen receptor (CAR-T... | Fatal | ReactionOutcome | CC BY-NC | 34876852 | 20,209,876 | 2021 |
What was the outcome of reaction 'Infection'? | Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience.
Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) have poor outcomes. Treatment with CD19 chimeric antigen receptor (CAR-T... | Fatal | ReactionOutcome | CC BY-NC | 34876852 | 20,209,876 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea'. | Pulmonary migration of liquid embolization material: An unusual cause of pulmonary embolism.
Iatrogenic non-thrombotic pulmonary embolism is a rare cause of pulmonary embolism. This case demonstrates the unusual imaging findings associated with pulmonary migration of Precipitating Hydrophobic Injectable Liquid, a liqui... | ACETAZOLAMIDE | DrugsGivenReaction | CC BY-NC-ND | 34876952 | 20,348,238 | 2022-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Pulmonary migration of liquid embolization material: An unusual cause of pulmonary embolism.
Iatrogenic non-thrombotic pulmonary embolism is a rare cause of pulmonary embolism. This case demonstrates the unusual imaging findings associated with pulmonary migration of Precipitating Hydrophobic Injectable Liquid, a liqui... | ACETAZOLAMIDE | DrugsGivenReaction | CC BY-NC-ND | 34876952 | 20,339,048 | 2022-02 |
What was the dosage of drug 'ACETAZOLAMIDE'? | Pulmonary migration of liquid embolization material: An unusual cause of pulmonary embolism.
Iatrogenic non-thrombotic pulmonary embolism is a rare cause of pulmonary embolism. This case demonstrates the unusual imaging findings associated with pulmonary migration of Precipitating Hydrophobic Injectable Liquid, a liqui... | UNK; THERAPY ADJUSTED | DrugDosageText | CC BY-NC-ND | 34876952 | 20,339,048 | 2022-02 |
What was the outcome of reaction 'Dyspnoea'? | Pulmonary migration of liquid embolization material: An unusual cause of pulmonary embolism.
Iatrogenic non-thrombotic pulmonary embolism is a rare cause of pulmonary embolism. This case demonstrates the unusual imaging findings associated with pulmonary migration of Precipitating Hydrophobic Injectable Liquid, a liqui... | Recovered | ReactionOutcome | CC BY-NC-ND | 34876952 | 20,339,048 | 2022-02 |
What was the administration route of drug 'AMOXICILLIN'? | Prevotella brain abscess in a healthy patient with a patent foramen ovale: Case report.
Brain abscesses are relatively rare life-threatening infectious lesions often concomitant with a direct spillover of inflammation in the head or neck, hematogenous infections, and immunocompromised conditions. They rarely occur in a... | Oral | DrugAdministrationRoute | CC BY-NC-SA | 34877034 | 20,680,758 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aspergillus infection'. | Aspergillus sphenoiditis growth on long cut ends of a non-absorbable sellar floor dura closure suture.
Cerebrospinal fluid (CSF) rhinorrhea is a common complication after transsphenoidal surgery (TSS). Suturing of sellar dura is effective in the prevention of postoperative CSF rhinorrhea, but it may cause rare postoper... | HYDROCORTISONE | DrugsGivenReaction | CC BY-NC-SA | 34877053 | 20,749,493 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinusitis'. | Aspergillus sphenoiditis growth on long cut ends of a non-absorbable sellar floor dura closure suture.
Cerebrospinal fluid (CSF) rhinorrhea is a common complication after transsphenoidal surgery (TSS). Suturing of sellar dura is effective in the prevention of postoperative CSF rhinorrhea, but it may cause rare postoper... | HYDROCORTISONE | DrugsGivenReaction | CC BY-NC-SA | 34877053 | 20,749,493 | 2021 |
What was the administration route of drug 'HYDROCORTISONE'? | Aspergillus sphenoiditis growth on long cut ends of a non-absorbable sellar floor dura closure suture.
Cerebrospinal fluid (CSF) rhinorrhea is a common complication after transsphenoidal surgery (TSS). Suturing of sellar dura is effective in the prevention of postoperative CSF rhinorrhea, but it may cause rare postoper... | Oral | DrugAdministrationRoute | CC BY-NC-SA | 34877053 | 20,749,493 | 2021 |
What was the outcome of reaction 'Aspergillus infection'? | Aspergillus sphenoiditis growth on long cut ends of a non-absorbable sellar floor dura closure suture.
Cerebrospinal fluid (CSF) rhinorrhea is a common complication after transsphenoidal surgery (TSS). Suturing of sellar dura is effective in the prevention of postoperative CSF rhinorrhea, but it may cause rare postoper... | Recovered | ReactionOutcome | CC BY-NC-SA | 34877053 | 20,749,493 | 2021 |
What was the outcome of reaction 'Sinusitis'? | Aspergillus sphenoiditis growth on long cut ends of a non-absorbable sellar floor dura closure suture.
Cerebrospinal fluid (CSF) rhinorrhea is a common complication after transsphenoidal surgery (TSS). Suturing of sellar dura is effective in the prevention of postoperative CSF rhinorrhea, but it may cause rare postoper... | Recovered | ReactionOutcome | CC BY-NC-SA | 34877053 | 20,749,493 | 2021 |
What was the dosage of drug 'MEGESTROL ACETATE'? | Regression of Multiple Meningiomas after Discontinuation of Chronic Hormone Therapy: A Case Report.
Introduction Meningiomas are more common in females and frequently express progesterone and estrogen receptors. Recent studies have revealed a high incidence of meningiomas in situations in which estrogen/progesterone l... | UNK, AT LEAST 20 YEARS | DrugDosageText | CC BY-NC-ND | 34877245 | 20,893,773 | 2021-10 |
What was the dosage of drug 'MEGESTROL'? | Regression of Multiple Meningiomas after Discontinuation of Chronic Hormone Therapy: A Case Report.
Introduction Meningiomas are more common in females and frequently express progesterone and estrogen receptors. Recent studies have revealed a high incidence of meningiomas in situations in which estrogen/progesterone l... | AT LEAST 20 YEARS | DrugDosageText | CC BY-NC-ND | 34877245 | 20,940,531 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthma'. | A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment.
Severe eosinophilic asthma is associated with a heavy burden and impact on daily living in patients experiencing uncontrolled symptoms, exacerbations, and treatment si... | ALBUTEROL, BETAMETHASONE, CETIRIZINE HYDROCHLORIDE, FLUTICASONE PROPIONATE\SALMETEROL XINAFOATE, MEPOLIZUMAB, MONTELUKAST SODIUM, PREDNISOLONE, THEOPHYLLINE, TIOTROPIUM BROMIDE, TRIAMCINOLONE | DrugsGivenReaction | CC BY-NC-ND | 34877251 | 20,620,940 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment.
Severe eosinophilic asthma is associated with a heavy burden and impact on daily living in patients experiencing uncontrolled symptoms, exacerbations, and treatment si... | CETIRIZINE HYDROCHLORIDE, FLUTICASONE PROPIONATE\SALMETEROL XINAFOATE, MEPOLIZUMAB, PREDNISOLONE, THEOPHYLLINE, TRIAMCINOLONE | DrugsGivenReaction | CC BY-NC-ND | 34877251 | 20,630,573 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rebound effect'. | A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment.
Severe eosinophilic asthma is associated with a heavy burden and impact on daily living in patients experiencing uncontrolled symptoms, exacerbations, and treatment si... | ALBUTEROL, BETAMETHASONE, CETIRIZINE HYDROCHLORIDE, FLUTICASONE PROPIONATE\SALMETEROL XINAFOATE, MEPOLIZUMAB, MONTELUKAST SODIUM, PREDNISOLONE, THEOPHYLLINE, TIOTROPIUM BROMIDE, TRIAMCINOLONE | DrugsGivenReaction | CC BY-NC-ND | 34877251 | 20,620,940 | 2021 |
What was the administration route of drug 'MEPOLIZUMAB'? | A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment.
Severe eosinophilic asthma is associated with a heavy burden and impact on daily living in patients experiencing uncontrolled symptoms, exacerbations, and treatment si... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 34877251 | 20,620,940 | 2021 |
What was the administration route of drug 'TRIAMCINOLONE'? | A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment.
Severe eosinophilic asthma is associated with a heavy burden and impact on daily living in patients experiencing uncontrolled symptoms, exacerbations, and treatment si... | Intramuscular | DrugAdministrationRoute | CC BY-NC-ND | 34877251 | 20,620,940 | 2021 |
What was the dosage of drug 'ALBUTEROL'? | A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment.
Severe eosinophilic asthma is associated with a heavy burden and impact on daily living in patients experiencing uncontrolled symptoms, exacerbations, and treatment si... | UNK, THE PATIENT RECEIVED SALBUTAMOL MORE THAN 20 PUFFS/WEEK | DrugDosageText | CC BY-NC-ND | 34877251 | 20,620,940 | 2021 |
What was the dosage of drug 'BETAMETHASONE'? | A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment.
Severe eosinophilic asthma is associated with a heavy burden and impact on daily living in patients experiencing uncontrolled symptoms, exacerbations, and treatment si... | 4.5 MG, QD | DrugDosageText | CC BY-NC-ND | 34877251 | 20,620,940 | 2021 |
What was the dosage of drug 'MONTELUKAST SODIUM'? | A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment.
Severe eosinophilic asthma is associated with a heavy burden and impact on daily living in patients experiencing uncontrolled symptoms, exacerbations, and treatment si... | 10 MG, QD | DrugDosageText | CC BY-NC-ND | 34877251 | 20,620,940 | 2021 |
What was the outcome of reaction 'Asthma'? | A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment.
Severe eosinophilic asthma is associated with a heavy burden and impact on daily living in patients experiencing uncontrolled symptoms, exacerbations, and treatment si... | Recovered | ReactionOutcome | CC BY-NC-ND | 34877251 | 20,620,940 | 2021 |
What was the outcome of reaction 'Rebound effect'? | A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment.
Severe eosinophilic asthma is associated with a heavy burden and impact on daily living in patients experiencing uncontrolled symptoms, exacerbations, and treatment si... | Recovered | ReactionOutcome | CC BY-NC-ND | 34877251 | 20,620,940 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bone marrow failure'. | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | METHOTREXATE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34877256 | 20,722,578 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Encephalopathy'. | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | FLUDARABINE PHOSPHATE, MELPHALAN, METHOTREXATE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34877256 | 20,699,931 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | FLUDARABINE PHOSPHATE, MELPHALAN, METHOTREXATE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34877256 | 20,699,931 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mouth haemorrhage'. | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | METHOTREXATE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34877256 | 20,722,578 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stomatitis'. | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | METHOTREXATE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34877256 | 20,722,578 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transplant failure'. | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | METHOTREXATE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34877256 | 20,722,578 | 2021 |
What was the administration route of drug 'CEFEPIME HYDROCHLORIDE'? | The first case of Janibacter hoylei bacteremia in an adult.
The Janibacter species are Gram positive, coryneform bacteria that belong to the Actinobacteria phylum and have been linked to bacteremia in immunocompromised children. We present the first documented adult case of Janibacter hoylei bacteremia. The patient was... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34877256 | 20,709,296 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.